Spinal Muscular Atrophy Treatment Global Market Report 2025

Published Jul 07, 2025

Length 175 Pages

SKU # BRC20166223

Description

Spinal Muscular Atrophy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal muscular atrophy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for spinal muscular atrophy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spinal muscular atrophy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Medication; Physical Therapy; Surgery; Other Treatments

2) By Type: Werdnig-Hoffmann Disease; Infant Spinal Muscular Atrophy; Kugelberg-Welander Disease; Adult Spinal Muscular Atrophy

3) By Route Of Administration: Oral; Parenteral

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Medication: Nusinersen (Spinraza); Onasemnogene Abeparvovec-Xioi (Zolgensma); Risdiplam (Evrysdi); Antisense Oligonucleotides; Spinal Muscular Atrophy (SMN2) Splicing Modifiers; Corticosteroids; Supportive Medications

2) By Physical Therapy: Occupational Therapy; Respiratory Therapy; Aquatic Therapy; Orthotic Support; Assistive Mobility Devices; Range-Of-Motion Exercises

3) By Surgery: Spinal Fusion Surgery; Scoliosis Correction Surgery; Orthopedic Surgery; Gastrostomy Tube Placement; Tracheostomy

4) By Other Treatments: Nutritional Support; Respiratory Support; Psychosocial Support And Counseling; Genetic Counseling; Stem Cell Therapy

Companies Mentioned: F. Hoffmann-La Roche Ltd; Novartis AG; Biogen Inc.; Chugai Pharmaceutical Co. Ltd; PTC Therapeutics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Spinal Muscular Atrophy Treatment Market Characteristics
3. Spinal Muscular Atrophy Treatment Market Trends And Strategies
4. Spinal Muscular Atrophy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Spinal Muscular Atrophy Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Spinal Muscular Atrophy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Spinal Muscular Atrophy Treatment Market Growth Rate Analysis; 5.4. Global Spinal Muscular Atrophy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Spinal Muscular Atrophy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Spinal Muscular Atrophy Treatment Total Addressable Market (TAM)
6. Spinal Muscular Atrophy Treatment Market Segmentation: 6.1. Global Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Medication; Physical Therapy; Surgery; Other Treatments; 6.2. Global Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Werdnig-Hoffmann Disease; Infant Spinal Muscular Atrophy (Sma); Kugelberg-Welander Disease; Adult Spinal Muscular Atrophy (Sma); 6.3. Global Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Parenteral; 6.4. Global Spinal Muscular Atrophy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels; 6.5. Global Spinal Muscular Atrophy Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Homecare; Specialty Clinics; Other End Users; 6.6. Global Spinal Muscular Atrophy Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Nusinersen (Spinraza); Onasemnogene Abeparvovec-Xioi (Zolgensma); Risdiplam (Evrysdi); Antisense Oligonucleotides; Spinal Muscular Atrophy (SMN2) Splicing Modifiers; Corticosteroids; Supportive Medications; 6.7. Global Spinal Muscular Atrophy Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Occupational Therapy; Respiratory Therapy; Aquatic Therapy; Orthotic Support; Assistive Mobility Devices; Range-Of-Motion Exercises; 6.8. Global Spinal Muscular Atrophy Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Spinal Fusion Surgery; Scoliosis Correction Surgery; Orthopedic Surgery; Gastrostomy Tube Placement; Tracheostomy; 6.9. Global Spinal Muscular Atrophy Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Nutritional Support; Respiratory Support; Psychosocial Support And Counseling; Genetic Counseling; Stem Cell Therapy
7. Spinal Muscular Atrophy Treatment Market Regional And Country Analysis: 7.1. Global Spinal Muscular Atrophy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Spinal Muscular Atrophy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Spinal Muscular Atrophy Treatment Market: 8.1. Asia-Pacific Spinal Muscular Atrophy Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Spinal Muscular Atrophy Treatment Market: 9.1. China Spinal Muscular Atrophy Treatment Market Overview; 9.2. China Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Spinal Muscular Atrophy Treatment Market: 10.1. India Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Spinal Muscular Atrophy Treatment Market: 11.1. Japan Spinal Muscular Atrophy Treatment Market Overview; 11.2. Japan Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Spinal Muscular Atrophy Treatment Market: 12.1. Australia Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Spinal Muscular Atrophy Treatment Market: 13.1. Indonesia Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Spinal Muscular Atrophy Treatment Market: 14.1. South Korea Spinal Muscular Atrophy Treatment Market Overview; 14.2. South Korea Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Spinal Muscular Atrophy Treatment Market: 15.1. Western Europe Spinal Muscular Atrophy Treatment Market Overview; 15.2. Western Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Spinal Muscular Atrophy Treatment Market: 16.1. UK Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Spinal Muscular Atrophy Treatment Market: 17.1. Germany Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Spinal Muscular Atrophy Treatment Market: 18.1. France Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Spinal Muscular Atrophy Treatment Market: 19.1. Italy Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Spinal Muscular Atrophy Treatment Market: 20.1. Spain Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Spinal Muscular Atrophy Treatment Market: 21.1. Eastern Europe Spinal Muscular Atrophy Treatment Market Overview; 21.2. Eastern Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Spinal Muscular Atrophy Treatment Market: 22.1. Russia Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Spinal Muscular Atrophy Treatment Market: 23.1. North America Spinal Muscular Atrophy Treatment Market Overview; 23.2. North America Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Spinal Muscular Atrophy Treatment Market: 24.1. USA Spinal Muscular Atrophy Treatment Market Overview; 24.2. USA Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Spinal Muscular Atrophy Treatment Market: 25.1. Canada Spinal Muscular Atrophy Treatment Market Overview; 25.2. Canada Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Spinal Muscular Atrophy Treatment Market: 26.1. South America Spinal Muscular Atrophy Treatment Market Overview; 26.2. South America Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Spinal Muscular Atrophy Treatment Market: 27.1. Brazil Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Spinal Muscular Atrophy Treatment Market: 28.1. Middle East Spinal Muscular Atrophy Treatment Market Overview; 28.2. Middle East Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Spinal Muscular Atrophy Treatment Market: 29.1. Africa Spinal Muscular Atrophy Treatment Market Overview; 29.2. Africa Spinal Muscular Atrophy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Spinal Muscular Atrophy Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Spinal Muscular Atrophy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Spinal Muscular Atrophy Treatment Market Competitive Landscape And Company Profiles: 30.1. Spinal Muscular Atrophy Treatment Market Competitive Landscape; 30.2. Spinal Muscular Atrophy Treatment Market Company Profiles; 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Chugai Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Spinal Muscular Atrophy Treatment Market Other Major And Innovative Companies: 31.1. Ionis Pharmaceuticals Inc.; 31.2. Ultragenyx Pharmaceutical Inc.; 31.3. Catalyst Pharmaceuticals Inc.; 31.4. BIOCAD INDIA PRIVATE LIMITED; 31.5. Cytokinetics Incorporated; 31.6. Voyager Therapeutics Inc.; 31.7. Scholar Rock Holding Corporation; 31.8. Genethon; 31.9. Exegenesis Bio Inc; 31.10. NMD Pharma A/S; 31.11. Biohaven Pharmaceutical Holding Company Ltd; 31.12. Alcyone Therapeutics Inc.; 31.13. Vybion Inc.; 31.14. Apteeus SAS; 31.15. Biophytis SA
32. Global Spinal Muscular Atrophy Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Spinal Muscular Atrophy Treatment Market
34. Recent Developments In The Spinal Muscular Atrophy Treatment Market
35. Spinal Muscular Atrophy Treatment Market High Potential Countries, Segments and Strategies: 35.1 Spinal Muscular Atrophy Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Spinal Muscular Atrophy Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Spinal Muscular Atrophy Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now